https://www.selleckchem.com/pr....oducts/lenalidomide-
Ulceration is a common complication of infantile hemangioma (IH), which leads to substantial morbidity. Ulceration in IH has not been systematically studied since the advent of β-blocker therapy for IH. To examine treatment interventions used for ulceration in IH and identify clinical prognostic indicators of healing time. A retrospective, multicenter cohort study was conducted on 436 consecutive patients with a clinical diagnosis of ulcerated IH and available clinical photographs. Patients receiving care at tertiary referral